U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Westar Nutrition Corp. dba: Viva Life Science, Inc. - Close Out Letter 6/13/18
  1. Warning Letters

CLOSEOUT LETTER

Westar Nutrition Corp. dba: Viva Life Science, Inc.


Recipient:
Westar Nutrition Corp. dba: Viva Life Science, Inc.


United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

 

 
Office of Human and Animal Foods Division West 5
Los Angeles District Office
19701 Fairchild, Irvine, CA 92612
Telephone: 949-608-4496 

UNITED PARCEL SERVICE
SIGNATURE REQUIRED

June 13, 2018

Emmanuel W. Fan, President/CEO
Westar Nutrition Corp. dba Viva Life Science, Inc.
350 Paularino Ave.
Costa Mesa, CA 92626

RE: WL #30-15 Close-Out Letter

Dear Mr. Fan:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter #30-15, dated July 22, 2015. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Sergio Chavez
Director Compliance Branch
Food and Drug Administration
HAF Division West 5